Medical Condition News

RSS

New artificial pancreas may provide life-changing support to diabetic people

For the 250,000 Canadians living with type 1 diabetes, the days of desperately trying to keep their blood sugar stable are coming to an end.

28 Feb 2020

Certain drugs can reduce epilepsy risk following traumatic brain injury

A research team led by a scientist at the University of California, Riverside, has found that brains treated with certain drugs within a few days of an injury have a dramatically reduced risk of developing epilepsy later in life.

28 Feb 2020

Gene-editing technology may lead to new model for studying Parkinson’s disease

Parkinson's disease researchers have used gene-editing tools to introduce the disorder's most common genetic mutation into marmoset monkey stem cells and to successfully tamp down cellular chemistry that often goes awry in Parkinson's patients.

27 Feb 2020

EHRA 2020: Latest practice-changing research in heart rhythm disorders

Get ready for the latest practice-changing research in heart rhythm disorders: presented at EHRA 2020, a scientific congress of the European Society of Cardiology.

27 Feb 2020

Two cutting-edge programs in neuroplasticity come together for a synergistic impact in brain health

Abilities Neurological Rehabilitation is excited to announce a new, collaborative treatment program to help individuals in the Fraser Valley who are living with chronic physical and cognitive symptoms following brain injury.

27 Feb 2020

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

An interdisciplinary team from the Institute of Radiopharmaceutical Cancer Research headed by Prof. Peter Brust has won HZDR's (Helmholtz-Zentrum Dresden-Rossendorf) third Innovation Contest.

27 Feb 2020

Nanoparticles containing gliadin could allow celiac disease patients to eat a normal diet

Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, but are often symptom-free.

27 Feb 2020

Boosting immune cells to treat eczema

A new drug regimen is reported to have marked benefits in treating the troublesome and distressing skin condition called eczema. The study, published in February 2020 in the journal Science Translational Medicine, shows that boosting the levels of a type of immune cell called natural killer cells can be a more effective way to treat eczema in a mouse study.

27 Feb 2020

Human stem cells cure diabetes in mice

Diabetes is characterized by elevated levels of blood sugar and is tied to various health complications. The condition is a global health issue with the number of people with diabetes increasing from 108 million in 1980 to 422 million in 2014.

27 Feb 2020

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

A new, phase I clinical trial offered The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute will treat patients with relapsed or refractory acute myeloid leukemia using a novel universal natural killer cell approach.

27 Feb 2020

Biomedical engineers develop handheld 3D printers to treat musculoskeletal injuries

Biomedical engineers at the UConn School of Dental Medicine recently developed a handheld 3D bioprinter that could revolutionize the way musculoskeletal surgical procedures are performed.

27 Feb 2020

New radiopharmaceutical could aid in more accurate diagnosis of neuroendocrine tumor metastases

The newly developed [55Co]55Co-DOTATATE imaging agent has emerged as a more accurate and sensitive radiopharmaceutical to aid in the diagnosis of neuroendocrine tumor metastases.

27 Feb 2020

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

A new phase II trial finds that a combination of radiation therapy and immunotherapy led to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and neck squamous cell carcinoma

27 Feb 2020

Scientists reveal ability to reverse Huntington's disease-causing DNA repeat mutations in the lab

Neurodegenerative diseases, like Huntington's disease and myotonic dystrophy, are often referred to as DNA repeat diseases, named because of long repeated sequences in the DNA of patients. Increasing repeat expansion length in the affected tissues contribute to earlier age of disease onset and worsen the progression and severity of the disease over time.

27 Feb 2020

Otago researchers involved in world's first trial to prevent TB in people with diabetes

Otago researchers are playing a leadership role in an Euro €4.8 million international project to conduct the world's first trial attempting to prevent tuberculosis in people with diabetes.

27 Feb 2020

Pre-operative immunotherapy can elicit an immune response that shrinks oral cancers

A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.

27 Feb 2020

Drug used for breast, renal cancers may provide survival benefit for patients with head and neck cancers

A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment.

27 Feb 2020

NTHU research team develops new treatment for cancer

A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide (NanoNO), which also facilitates the delivery of cancer drugs and immunocytes into the tumor.

27 Feb 2020

New European collaboration to accelerate lifesaving cancer research

Cancer Research UK and its European partners, Fondazione AIRC and Asociación Española Contra el Cáncer (AECC), will invest £27.4 million into seven new international projects to accelerate lifesaving cancer research, announced today (Friday).

27 Feb 2020

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF)as a treatment for Parkinson's disease.

27 Feb 2020

Medical Condition News

New artificial pancreas may provide life-changing support to diabetic people

Certain drugs can reduce epilepsy risk following traumatic brain injury

Gene-editing technology may lead to new model for studying Parkinson’s disease

EHRA 2020: Latest practice-changing research in heart rhythm disorders

Two cutting-edge programs in neuroplasticity come together for a synergistic impact in brain health

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

Nanoparticles containing gliadin could allow celiac disease patients to eat a normal diet

Boosting immune cells to treat eczema

Human stem cells cure diabetes in mice

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

Biomedical engineers develop handheld 3D printers to treat musculoskeletal injuries

New radiopharmaceutical could aid in more accurate diagnosis of neuroendocrine tumor metastases

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

Scientists reveal ability to reverse Huntington's disease-causing DNA repeat mutations in the lab

Otago researchers involved in world's first trial to prevent TB in people with diabetes

Pre-operative immunotherapy can elicit an immune response that shrinks oral cancers

Drug used for breast, renal cancers may provide survival benefit for patients with head and neck cancers

NTHU research team develops new treatment for cancer

New European collaboration to accelerate lifesaving cancer research

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News